Research status and prospect of non-viral vectors based on siRNA: a review

L Tong, D Liu, Z Cao, N Zheng, C Mao, S Liu… - International journal of …, 2023 - mdpi.com
Gene therapy has attracted much attention because of its unique mechanism of action, non-
toxicity, and good tolerance, which can kill cancer cells without damaging healthy tissues …

A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement

A De, YT Ko - Expert Opinion on Drug Delivery, 2023 - Taylor & Francis
ABSTRACT Introduction Ionizable lipid nanoparticles (LNPs) have been proven to have high
encapsulation, cellular uptake, and effective endosomal escape and are therefore promising …

A review on stimuli-pH responsive liposomal formulation in cancer therapy

P Jayapriya, E Pardhi, R Vasave, SK Guru… - Journal of Drug Delivery …, 2023 - Elsevier
Numerous advancements in drug delivery systems are currently underway to mitigate the
gross toxicity of cytotoxic drugs and enhance their therapeutic efficacy and selectivity. The …

Nanomedicine-RNAi interface: Architypes in prostate cancer therapeutics

S Shah, P Famta, DA Srinivasarao, S Shahrukh… - Journal of Drug Delivery …, 2024 - Elsevier
Prostate cancer (PCa) is the most frequent cancer among men throughout the world. The
available conventional therapies such as androgen deprivation therapy and surgical …

Encapsulated Docetaxel in Synthesized PCL-PEG-PCL Nano-Carriers as a Strategy for Controlled Drug Delivery in Breast Cancer

A Khojastehfar, E Zabihi, A Mostafazadeh… - 2023 - researchsquare.com
Background Nano-drug delivery systems are rapidly evolving in the treatment of cancer due
to reduced side effects and improved therapeutic properties of drugs through the drugs' slow …